Spots Global Cancer Trial Database for lung cancer anti angiogenesis therapy survival
Every month we try and update this database with for lung cancer anti angiogenesis therapy survival cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC | NCT02497118 | Non Small Cell ... | Endostatin Vinorelbine Cisplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital |